Literature DB >> 18644954

Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa.

Mette E Skindersoe1, Morten Alhede, Richard Phipps, Liang Yang, Peter O Jensen, Thomas B Rasmussen, Thomas Bjarnsholt, Tim Tolker-Nielsen, Niels Høiby, Michael Givskov.   

Abstract

During infection, Pseudomonas aeruginosa employs bacterial communication (quorum sensing [QS]) to coordinate the expression of tissue-damaging factors. QS-controlled gene expression plays a pivotal role in the virulence of P. aeruginosa, and QS-deficient mutants cause less severe infections in animal infection models. Treatment of cystic fibrosis (CF) patients chronically infected with P. aeruginosa with the macrolide antibiotic azithromycin (AZM) has been demonstrated to improve the clinical outcome. Several studies indicate that AZM may accomplish its beneficial action in CF patients by impeding QS, thereby reducing the pathogenicity of P. aeruginosa. This led us to investigate whether QS inhibition is a common feature of antibiotics. We present the results of a screening of 12 antibiotics for their QS-inhibitory activities using a previously described QS inhibitor selector 1 strain. Three of the antibiotics tested, AZM, ceftazidime (CFT), and ciprofloxacin (CPR), were very active in the assay and were further examined for their effects on QS-regulated virulence factor production in P. aeruginosa. The effects of the three antibiotics administered at subinhibitory concentrations were investigated by use of DNA microarrays. Consistent results from the virulence factor assays, reverse transcription-PCR, and the DNA microarrays support the finding that AZM, CFT, and CPR decrease the expression of a range of QS-regulated virulence factors. The data suggest that the underlying mechanism may be mediated by changes in membrane permeability, thereby influencing the flux of N-3-oxo-dodecanoyl-L-homoserine lactone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644954      PMCID: PMC2565867          DOI: 10.1128/AAC.01230-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  90 in total

1.  Characterization of Pseudomonas aeruginosa chitinase, a gradually secreted protein.

Authors:  J Folders; J Algra; M S Roelofs; L C van Loon; J Tommassen; W Bitter
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

2.  Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation.

Authors:  C A DeVries; D E Ohman
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

3.  Cloning and expression in Escherichia coli of the gene for extracellular phospholipase A1 from Serratia liquefaciens.

Authors:  M Givskov; L Olsen; S Molin
Journal:  J Bacteriol       Date:  1988-12       Impact factor: 3.490

4.  Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa.

Authors:  P J Wilderman; A I Vasil; Z Johnson; M J Wilson; H E Cunliffe; I L Lamont; M L Vasil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules.

Authors:  Doreen S W Hooi; Barrie W Bycroft; Siri Ram Chhabra; Paul Williams; David I Pritchard
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms.

Authors:  Yannick Lequette; E P Greenberg
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

7.  Expression stability of six housekeeping genes: A proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR.

Authors:  Hakan Savli; Aynur Karadenizli; Fetiye Kolayli; Sibel Gundes; Ugur Ozbek; Haluk Vahaboglu
Journal:  J Med Microbiol       Date:  2003-05       Impact factor: 2.472

8.  Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.

Authors:  Nadine Hoffmann; Baoleri Lee; Morten Hentzer; Thomas Bovbjerg Rasmussen; Zhijun Song; Helle Krogh Johansen; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

9.  Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.

Authors:  Robert K Flamm; Mellany K Weaver; Clyde Thornsberry; Mark E Jones; James A Karlowsky; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  Production and properties of heat-stable extracellular hemolysin from Pseudomonas aeruginosa.

Authors:  M K Johnson; D Boese-Marrazzo
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more
  109 in total

Review 1.  Role of quorum sensing in bacterial infections.

Authors:  Israel Castillo-Juárez; Toshinari Maeda; Edna Ayerim Mandujano-Tinoco; María Tomás; Berenice Pérez-Eretza; Silvia Julieta García-Contreras; Thomas K Wood; Rodolfo García-Contreras
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

2.  Synergistic effect of 14-alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa.

Authors:  Xiangping Zeng; Xiangyang Liu; Jiang Bian; Gang Pei; Huanqin Dai; Steven W Polyak; Fuhang Song; Li Ma; Yuqiang Wang; Lixin Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Food as a source for quorum sensing inhibitors: iberin from horseradish revealed as a quorum sensing inhibitor of Pseudomonas aeruginosa.

Authors:  Tim Holm Jakobsen; Steinn Kristinn Bragason; Richard Kerry Phipps; Louise Dahl Christensen; Maria van Gennip; Morten Alhede; Mette Skindersoe; Thomas Ostenfeld Larsen; Niels Høiby; Thomas Bjarnsholt; Michael Givskov
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

Review 4.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

Review 5.  Resistance to quorum-quenching compounds.

Authors:  Rodolfo García-Contreras; Toshinari Maeda; Thomas K Wood
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

6.  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Authors:  Athanasios Chatzimoschou; Maria Simitsopoulou; Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

7.  Inhibition of marine biofouling by bacterial quorum sensing inhibitors.

Authors:  Sergey Dobretsov; Max Teplitski; Mirko Bayer; Sarath Gunasekera; Peter Proksch; Valerie J Paul
Journal:  Biofouling       Date:  2011-09       Impact factor: 3.209

Review 8.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

9.  Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Tim Holm Jakobsen; Richard Phipps; Anne Kirstine Nielsen; Morten Theil Rybtke; Tim Tolker-Nielsen; Michael Givskov; Niels Høiby; Oana Ciofu
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

10.  Anti-inflammatory effects of antibacterials on human Bronchial epithelial cells.

Authors:  Gregor S Zimmermann; Claus Neurohr; Heidrun Villena-Hermoza; Rudolf Hatz; Juergen Behr
Journal:  Respir Res       Date:  2009-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.